论文部分内容阅读
随着我国加入WTO,如何更好地对TRIPS协议加以利用成为我们继续研究的课题。尤其是中国作为发展中国家,目前还没有完全利用TRIPS协议中有关的弹性规定,甚至更糟的是,一些规定直接模仿TRIPS协议和美国的相关实践,这大大减少了弹性规定的可利用空间。本文正是从此背景入手,运用专利法方面的一般理论,对药品专利的实质要件加以细致地分析,期望能够对中国药品专利保护制度的发展有所贡献。
With China's accession to the WTO, how to make better use of the TRIPS Agreement becomes a topic that we continue to study. In particular, China, as a developing country, has not fully utilized the relevant flexibilities stipulated in the TRIPS agreement. Even worse, some of the provisions directly imitate the TRIPS agreement and the relevant U.S. practices. This greatly reduces the available space for flexibility provisions. Starting from this background, this article uses the general theory of patent law to analyze the essential elements of drug patents in detail, and hopes to make some contribution to the development of the system of drug patent protection in China.